P
CME icon

&Partners’s CME Group CME Stock Holding History

&Partners’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.1M Sell
99,362
-1,096
-1% -$303K 0.09% 206
2026
Q1 		$29.7M Buy
100,458
+9,124
+10% +$2.71M 0.15% 127
2025
Q4 		$24.9M Buy
91,334
+26,135
+40% +$7.1M 0.13% 148
2025
Q3 		$17.7M Buy
65,199
+8,942
+16% +$2.43M 0.11% 169
2025
Q2 		$15.5M Buy
56,257
+12,089
+27% +$3.29M 0.12% 170
2025
Q1 		$11.6M Sell
44,168
-837
-2% -$206K 0.12% 161
2024
Q4 		$10.5M Buy
45,005
+14,648
+48% +$3.37M 0.13% 164
2024
Q3 		$6.69M Buy
30,357
+28,360
+1,420% +$5.87M 0.13% 163
2024
Q2 		$393K Buy
+1,997
New +$413K 0.02% 624

Other funds holding CME

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

&Partners's CME Position: Q2 2026 in Review

&Partners reduced its CME Group (CME) stake by 1.1% in Q2 2026, selling an estimated $303K and leaving 99,362 shares worth $22.1M. The position accounts for 0.09% of the portfolio, ranked #206.

&Partners first reported a position in CME in Q2 2024 and has held it in 9 quarters since. The position peaked at $29.7M in Q1 2026. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • &Partners held 99,362 shares of CME Group worth $22.1M as of Q2 2026.
  • &Partners sold 1,096 CME Group shares in Q2 2026, an estimated $303K.
  • CME Group made up 0.09% of &Partners's portfolio in Q2 2026, its #206 holding.
  • &Partners first reported a position in CME Group in Q2 2024 and has held it in 9 quarters since.
  • &Partners's CME Group position peaked at $29.7M in Q1 2026.
  • 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.